Neonatal jaundice continues to be a significant issue in new child treatment, affecting as much as sixty% of whole-time period infants. the necessity for accurate, non-invasive bilirubin measurement has driven healthcare diagnostic devices producers to acquire advanced answers. Transcutaneous bilirubinometers have emerged being a activity-modifying